ch.oddb.org
 
Apotheken | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsi.
Fachinformation zu Andursil®:Dr. Heinz Welti AG, Fabrikation chemisch-pharmazeutischer Produkte
Vollst. FachinformationDDDÄnderungen anzeigenDrucken 
Zusammens.Galen.FormInd./Anw.mögl.Dos./Anw.Kontraind.Warn.hinw.Interakt.Schwangerschaft
Fahrtücht.Unerw.WirkungenÜberdos.Eigensch.Pharm.kinetikPräklin.Sonstige H.Swissmedic-Nr.
PackungenReg.InhaberStand d. Info. 
A02AF02 - Ordinary Salt Combinations and AntiflatulentsATC-DDD Version 2016. Source: WHO
A - Alimentary Tract and Metabolism
 
A02 - Drugs for Acid Related Disorders
 
A02A - Antacids

This group comprises plain antacid drugs, antacids in combination with antiflatulents and antacids in combination with other drugs.
Antacids in combination with liquorice root or linseed are classified in this group.
Plain antiflatulents, see A03AX - Other drugs for functional gastrointestinal disorders.

The DDDs for antacids are based on treatment of hyperacidity and dyspepsia, not ulcus. One exception, however, is antacids in combination with antispasmodics in A02AG, where the DDDs are based on treatment of ulcus.
For ordinary salt combinations in A02AD, fixed doses are used instead of individual doses for every single preparation (10 tablets = 10 UD; 50 ml mixture = 10 UD).

A02AF - Antacids with Antiflatulents
 
A02AF02 - Ordinary Salt Combinations and Antiflatulents
2020 ©ywesee GmbH
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home